Document is current
Any future updates will be listed below
-
Authors
Chen, Xuelan
Agustinus, Albert S.
Li, Jun
DiBona, Melody https://orcid.org/0000-0002-8853-2604
Bakhoum, Samuel F. https://orcid.org/0000-0002-4779-8422
- License Information
-
More Information
Article History
Accepted: 25 June 2024
First Online: 29 July 2024
Competing interests
: S.F.B. holds a patent related to some of the work described targeting chromosomal instability (CIN) and the cGAS–STING pathway in advanced cancer; and owns equity in, receives compensation from, serves as a consultant for and serves on the Scientific Advisory Board (SAB) and Board of Directors (BOD) of Volastra Therapeutics Inc., and serves on the SAB of Meliora Therapeutics. The other authors declare no competing interests.
